ICON plc
The Early Development Global Regulatory Lead provides strategic regulatory leadership across the development lifecycle of innovative therapeutics, guiding global regulatory strategy from preclinical activities through First-in-Human studies and early clinical development. This senior leader serves as a key business partner to development teams, driving patient-focused regulatory strategies, supporting accelerated pathways, and leading agency interactions to ensure successful program transitions. The role involves mentoring regulatory staff, collaborating with cross-functional stakeholders, and monitoring evolving global regulatory requirements.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
ICON plc didn’t post a salary, so this is our estimate from similar listings.
Senior Director, Regulatory Strategy – Global Regulatory Lead
Beeline Medicines
Early Development Global Regulatory Lead
argenx
Senior Manager, Global Regulatory Strategy
Telix Pharmaceuticals
Regulatory Affairs Lead
BeOne Medicines
Manager, Regulatory Affairs
Maze Therapeutics
GVP, Global Regulatory Affairs
Kiniksa Pharmaceuticals